KARD (Kardigan) Total Liabilities: $641.28 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KARD Kardigan Inc KARD
11 GF Score
Price $20.42
! 1 Warning Sign
View Full Analysis

What is Kardigan Total Liabilities?

Kardigan KARD +2.77% 11 Total Liabilities is $641.28 Mil as of Dec. 2025. GuruFocus rates KARD with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Kardigan's Total Liabilities for the quarter that ended in Dec. 2025 was $641.28 Mil.

Kardigan's quarterly Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($146.72 Mil) and increased from Dec. 2024 ($146.72 Mil) to Dec. 2025 ($641.28 Mil).

Kardigan's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($146.72 Mil) and increased from Dec. 2024 ($146.72 Mil) to Dec. 2025 ($641.28 Mil).

Kardigan Total Liabilities Historical Data

* Premium members only.

The historical data trend for Kardigan's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kardigan Total Liabilities Chart

Kardigan Annual Data
Trend Dec24 Dec25
Total Liabilities
146.72 641.28

Kardigan Semi-Annual Data
Dec24 Dec25
Total Liabilities 146.72 641.28
KARD
11GF Score
Kardigan Inc KARD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kardigan Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kardigan's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.536+(10.689+593.052
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=641.28

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=390.942--250.335
=641.28

Kardigan's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.536+(10.689+593.052
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=641.28

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=390.942--250.335
=641.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $641.28 Mil mean?
Kardigan (KARD) has a Total Liabilities of $641.28 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kardigan and its competitors.
Is Kardigan's Total Liabilities too high?
Kardigan's current Total Liabilities is $641.28 Mil. Overall, Kardigan has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Kardigan's Total Liabilities compare to OCUL and GHRS?
Kardigan's Total Liabilities of $641.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kardigan and its competitors. Kardigan's current Total Liabilities is $641.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kardigan stock overvalued right now?
Kardigan (KARD) has a current Total Liabilities of $641.28 Mil. The current Total Liabilities is $641.28 Mil. Kardigan's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kardigan (KARD), the current Total Liabilities is $641.28 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kardigan Business Description

Address 506 Carnegie Center Drive, Suite 201, Princeton, NJ, USA, 08540
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
11GF Score

Get the complete analysis for KARD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.42
Price